You have no items in your shopping cart.
Search results for: 'SARS-CoV-2'
ELISA, MS, SDS-PAGE, WB
Greater than 95% as determined by reducing SDS-PAGE.
Human cells
50 μg, 500 μgELISA, MS, SDS-PAGE, WB
Greater than 95% as determined by reducing SDS-PAGE.
Human cells
50 μg, 500 μgELISA, MS, SDS-PAGE, WB
Greater than 95% as determined by reducing SDS-PAGE.
Human cells
50 μg, 500 μgELISA, MS, SDS-PAGE, WB
Greater than 95% as determined by reducing SDS-PAGE.
Human cells
500 μg, 50 μg- Featured
Featured
Unconjugated
The purity of the protein is greater than 85% as determined by SDS-PAGE and Coomassie blue staining.
The protein has a predicted molecular mass of 46.3 kDa after removal of the signal peptide. The apparent molecular mass of Nucleocapsid (D63G, R203M, D377Y)-His is approximately 55-70 kDa due to glycosylation.
Mammalian
Nucleocapsid (P13L, E31del, R32del, S33del, R203K, G204R)(Met1-Ala419) 6×His tag
C-6×His Tag
50 μg, 10 μg, 100 μg ELISA, IF
Virus
Mouse
Monoclonal
Unconjugated
0.1 mgELISA, IHC
Virus
Rabbit
Monoclonal
Unconjugated
0.1 mgELISA, WB
Mouse
Recombinant
Unconjugated
0.1 mgELISA, WB
> 95% as determined by Bis-Tris PAGE; > 95% as determined by HPLCEndotoxin level is less than 1EU per ug by the LAL method.
HEK293 cells
His-Avi
0.1 mg- Featured
Featured
ELISA, WB
< 95%
42.9 kD
HEK293 cells
His tag at C-terminus
0.1 mg





![SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [3866]](/images/pub/media/catalog/product/NewWebsite/15/orb1273021_1.jpg)
![SARS-CoV-2 (COVID-19) Spike S1 Antibody [SP422]](/images/pub/media/catalog/product/NewWebsite/15/orb1274178_e_internal_1.jpg)


